TAOP vs PHIO Comparison

Taoping Inc is a provider of cloud-based technology solutions, smart city IoT platforms, digital advertising delivery systems, and internet-based information distribution systems in China. The company has three reportable segments. The Cloud-based Technology segment includes cloud-based products, high-end data storage servers, advertising services, and customized software solutions for private sector customers. The Traditional Information Technology segment includes project-based technology products and services sold to the public sector, including Geographic Information Systems, Digital Public Security Technology, and Digital Hospital Information Systems. The Smart Elevator segment provides elevator sales, installation, maintenance, renovation, and cloud-based maintenance services.

Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.